Jeff Cohn | executive |
Craig Collard | executive |
Ira Duarte | executive |
Carl Byrnes | analyst |
Serge Belanger | analyst |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2023 Earnings Conference Call.
As a reminder, this conference is being recorded.
Now I'd like to turn the call over to Jeff Cohn, Executive Director, Assistant General Counsel and Assistant Secretary. Please proceed.